AGAMREE

Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Rare Disease Expansion Deal

ROME, Italy and CORAL GABLES, Florida, United States – May 7, 2026 Angelini Pharma S.p.A. and Catalyst Pharmaceuticals Inc....

By cGxPwire Editor
May 8, 2026

Bio-Pharma

Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion

PRATTELN, Switzerland, April 27, 2026 Santhera Pharmaceuticals has achieved a significant regulatory milestone with the European Medicines Agency’s (EMA)...

By cGxPwire Editor
April 27, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

AGAMREE

Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Rare Disease Expansion Deal

Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion